Loading...

SOHO 2026 Annual Meeting

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Home Posters by Code Posters by Title Authors Affiliations Topics Sessions Videos Audios Previous meetings

Posters by Title

Type your Poster Title, then hit apply

Showing 1,267 results.

Thumbnail for Elevated Interleukin 1ί and Reduced Interleukin 5 in Low-Risk Myelodysplastic Syndromes with Grade 2 or Higher Bone Marrow Fibrosis

MDS - 1103

Elevated Interleukin 1ί and Reduced Interleukin 5 in Low-Risk Myelodysplastic Syndromes with Grade 2 or Higher Bone Marrow Fibrosis

Maria Stella Martino

Poster Presenter: Maria Stella Martino

Thumbnail for Elranatamab in Combination With Daratumumab and Lenalidomide (EDR) in Transplant-Ineligible (TI) Patients With Newly Diagnosed Multiple Myeloma (NDMM): Results From MagnetisMM-6 Part

MM - 1833

Elranatamab in Combination With Daratumumab and Lenalidomide (EDR) in Transplant-Ineligible (TI) Patients With Newly Diagnosed Multiple Myeloma (NDMM): Results From MagnetisMM-6 Part

Carmine Liberatore, Sherry Mathew

Poster Presenter: Sherry Mathew

Previous 1...45 46 47 48 49 50 51...141 Next

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

Thumbnail for Elritercept vs epoetin alfa in erythropoiesis-stimulating agent (ESA)-naοve adults with lower-risk myelodysplastic syndromes (MDS) and transfusion-dependent anemia: The ELRiSE MDS phase 3 study

MDS - 824

Elritercept vs epoetin alfa in erythropoiesis-stimulating agent (ESA)-naοve adults with lower-risk myelodysplastic syndromes (MDS) and transfusion-dependent anemia: The ELRiSE MDS phase 3 study

Valeria Santini

Poster Presenter: Valeria Santini

Thumbnail for ENABLE: A Phase 1 Study of ELVN-001, a Novel, Selective ATP-Competitive Inhibitor of BCR::ABL1, in Patients With Previously Treated CP-CML

CML - 652

ENABLE: A Phase 1 Study of ELVN-001, a Novel, Selective ATP-Competitive Inhibitor of BCR::ABL1, in Patients With Previously Treated CP-CML

Fadi G Haddad

Poster Presenter: Fadi G Haddad

Thumbnail for Endoscopic Diagnosis of Gastrointestinal Acute Graft-vs-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis of Biopsy Site, Procedure Selection, and CMV Co-Infection

CT - 1555

Endoscopic Diagnosis of Gastrointestinal Acute Graft-vs-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis of Biopsy Site, Procedure Selection, and CMV Co-Infection

Santoshini Adivi

Poster Presenter: Santoshini Adivi

Thumbnail for Environmental Double Burden in Multiple Myeloma: PM2.5 Exposure and Racial Outcome Disparities Among Non-Hispanic Black and White Patients in the United States

MM - 1637

Environmental Double Burden in Multiple Myeloma: PM2.5 Exposure and Racial Outcome Disparities Among Non-Hispanic Black and White Patients in the United States

Sai Lahari Sangaraju

Poster Presenter: Sai Lahari Sangaraju

$Thumbnail for EPCORE NHL-6: Phase 2 Study of Subcutaneous Epcoritamab as Outpatient Treatment for 2L+ Relapsed/Refractory Diffuse Large B-cell Lymphoma (R/R DLBCL)$

ABCL - 615

EPCORE NHL-6: Phase 2 Study of Subcutaneous Epcoritamab as Outpatient Treatment for 2L+ Relapsed/Refractory Diffuse Large B-cell Lymphoma (R/R DLBCL)

Christina Y Lee

Poster Presenter: Christina Y Lee

$Thumbnail for Epcoritamab + Chemoimmunotherapy in Patients With Relapsed/Refractory Large B-Cell Lymphoma Eligible for Autologous Stem Cell Transplant: Pooled Results From Arms 4 and 10 of EPCORE NHL-2$

ABCL - 619

Epcoritamab + Chemoimmunotherapy in Patients With Relapsed/Refractory Large B-Cell Lymphoma Eligible for Autologous Stem Cell Transplant: Pooled Results From Arms 4 and 10 of EPCORE NHL-2

Jon Ukropec

Poster Presenter: Jon Ukropec

Thumbnail for Epetraborole Demonstrates an Exposure-Dependent Effect on Erythropoiesis in Healthy Subjects

MPN - 1041

Epetraborole Demonstrates an Exposure-Dependent Effect on Erythropoiesis in Healthy Subjects

George H. Talbot

Poster Presenter: George H. Talbot

ePosters in

Topics Sessions

Acute Lymphoblastic Leukemia (ALL)(71)Acute Myeloid Leukemia (AML)(230)Aggressive B-Cell Lymphoma (ABCL)(114)Cellular Therapy (CT)(128)Chronic Lymphocytic Leukemia (CLL)(110)Chronic Myeloid Leukemia (CML)(55)Hodgkin Lymphoma (HL)(54)Indolent B-Cell Lymphoma (IBCL)(47)Mantle Cell Lymphoma (MCL)(23)Multiple Myeloma (MM)(234)

Previous 1 2 Next

Sponsors

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.